(Q38464751)

3 September 2017

1 reference

title

Beta-blocker use in systolic heart failure and dilated cardiomyopathy (English)

1 reference

3 September 2017

main subject

systolic heart failure

1 reference

Hash TW 2nd

1

1 reference

3 September 2017

Prisant LM

series ordinal

2

1 reference

3 September 2017

publication date

1 January 1997

1 reference

The Journal of Clinical Pharmacology

3 September 2017

published in

1 reference

3 September 2017

volume

37

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

7-19

1 reference

The epidemiology of heart failure: the Framingham Study

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Management of heart failure. I. Pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

The xamoterol experience in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Controlled trials with beta blockers in heart failure: metoprolol as the prototype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

The paradox of beta-adrenergic blockade for the management of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Usefulness of bucindolol in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009703700103

10.1177/009127009703700103

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference